PL
CVAC

Parkwood LLC’s CureVac CVAC Stock Holding History

Parkwood LLC’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-30,604
Closed -$209K – 144
2023
Q3 		$209K Buy
+30,604
New +$270K 0.02% 126

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Parkwood LLC's CVAC Position: Q4 2023 in Review

Parkwood LLC sold out of CureVac (CVAC) in Q4 2023, closing a stake of 30,604 shares — an estimated $209K sold.

Parkwood LLC first reported a position in CVAC in Q3 2023 and held it in 1 quarter. The position peaked at $209K in Q3 2023. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

  • Parkwood LLC reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
  • Parkwood LLC sold 30,604 CureVac shares in Q4 2023, an estimated $209K.
  • Parkwood LLC first reported a position in CureVac in Q3 2023 and held it in 1 quarter.
  • Parkwood LLC's CureVac position peaked at $209K in Q3 2023.
  • 90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Parkwood LLC's 13F filing for Q4 2023, filed 14 Feb 2024.